+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Electroceuticals/Bioelectric Medicine Market Size, Share & Trends Analysis Report By Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants), By Type, By Application, By End-Use, And Segment Forecasts, 2019 - 2026

  • ID: 4209704
  • Report
  • September 2019
  • Region: Global
  • 145 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Biotronik
  • Boston Scientific
  • Cochlear Ltd.
  • ElectroCore Inc.,
  • LivaNova PLC
  • MORE
The global electroceuticals/bioelectric medicine market size is expected to reach USD 28.5 billion by 2026, according to this report. It is projected to expand at a CAGR of 7.4% during the forecast period. Rising geriatric population, in need of bioelectric medicine is the major factor expected to propel growth during the forecast period. Aging population is prone to medical disorders such as cardiac arrhythmias, Parkinson's disease, Alzheimer's disease, epilepsy, and depression. Advanced electroceuticals including implantable cardioverter defibrillators, cochlear implants, cardiac pacemakers, and spinal cord stimulators, are used for the treatment of these conditions.

Increasing investment in the development of advanced bioelectric medicine is another major factor supporting the growth of the electroceuticals market. For instance, in FY 2016, Medtronic, invested around USD 2,224.0 million in R&D for the development of advanced products. According to, ElectroCore, almost 325,000 people in the U.S. experience cluster headache every year. The company, in an attempt to capitalize the untapped opportunity came up with a product which received FDA clearance in 2018 namely gammaCore, a noninvasive VNS therapy, helpful in managing painful headaches in adults.

Further Key Findings from the Report Suggest:
  • Implantable cardioverter defibrillators segment was the largest revenue-generating segment of the electroceuticals market in 2018 owing to wider application of these products in the treatment of arrhythmia
  • The implantable electroceuticals segment accounted for the largest revenue share in the bioelectric medicine market in 2018 owing to technological advancements
  • In the application segment, the arrhythmia segment accounted for the largest share in 2018 and is expected to maintain its dominance throughout forecast period
  • The hospitals dominated the electroceuticals end use market in terms of revenue in 2018 due to the escalating number of electroceutical devices implant procedures in hospitals
  • The North America bioelectric medicine market is the leading regional sector and accounted for the largest revenue share in 2018 mainly due to the of large number of medical devices companies in this region
  • The Asia Pacific region is expected to grow at a highest growth rate during the study period. The developing healthcare infrastructure and rising healthcare awareness in the Asian countries such as China and India is a major factor contributing to the growth of this region
  • Some of the major players in the electroceuticals/bioelectric medicine market include Medtronic; St. Jude Medical; Boston Scientific Corporation; Cochlear Ltd.; Sonova; LivaNova PLC; Biotronik; Nevro Corp.; SECOND SIGHT; and electroCore LLC.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Biotronik
  • Boston Scientific
  • Cochlear Ltd.
  • ElectroCore Inc.,
  • LivaNova PLC
  • MORE
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 Internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.5.1 Data for primary interviews in North america
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume price analysis (Model 2)
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Market Trend

Chapter 3 Electroceutical/Bioelectric Medicine Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Increasing incidence of related disorders
3.1.1.2 Favorable reimbursement policies and grants
3.1.1.3 Growing geriatric population
3.1.1.4 Growing adoption of sedentary lifestyle
3.1.2 Market Restrain Analysis
3.1.2.1 Stringent regulatory framework
3.1.2.2 Product recall
3.2 Technology Trend Analysis
3.3 Disease Prevalence
3.4 Electroceutical/Bioelectric Medicine: Market Analysis Tools
3.4.1 Industry Analysis-Porter’s
3.4.2 Pestle Analysis
3.4.3 Major Deals And Strategic Alliances
3.4.4 Reimbursement Landscape
3.4.4.1 Reimbursement framework
3.4.4.2 Standards & compliance
3.4.4.2.1 CPT Coding implications
3.4.4.3 List of regulations, by country

Chapter 4 Electroceutical/Bioelectric Medicine Market: Segment Analysis, By Type, 2014-2026 (USD Million)
4.1 Definition and Scope
4.2 Type Market Share Analysis, 2018 & 2026
4.3 Segment Dashboard
4.4 Global Electroceutical/Bioelectric Medicine Market, by Type, 2014 to 2026
4.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026
4.5.1 ImplanTable Electroceutical Device
4.5.1.1 ImplanTable Electroceutical Device market, 2014-2026 (USD Million)
4.5.2 Non-invasive electroceutical devices
4.5.2.1 Non-invasive electroceutical devices market, 2014-2026 (USD Million)

Chapter 5 Electroceutical/Bioelectric Medicine Market: Segment Analysis, By Product, 2014-2026 (USD Million)
5.1 Definition and Scope
5.2 Product Market Share Analysis, 2018 & 2026
5.3 Segment Dashboard
5.4 Global Electroceutical/Bioelectric Medicine Market, by Product, 2014 to 2026
5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026
5.5.1 ImplanTable Cardioverter Defibrillators (ICD)
5.5.1.1 ImplanTable cardioverter defibrillators market, 2014-2026 (USD Million)
5.5.2 Cardiac Pacemaker
5.5.2.1 Cardiac Pacemaker Market, 2014-2026 (Usd Million)
5.5.3 Cochlear Implant
5.5.3.1 Cochlear implant market, 2014-2026 (USD Million)
5.5.4 Spinal Cord Stimulators (SCS)
5.5.4.1 SCS market, 2014-2026 (USD Million)
5.5.5 Deeb Brain Stimulators (DBS)
5.5.5.1 DBS market, 2014-2026 (USD Million)
5.5.6 Transcutaneous Electrical Nerve Stimulators (TENS)
5.5.6.1 Transcutaneous electrical nerve stimulatorsmarket, 2014-2026 (USD Million)
5.5.7 Scaral Nerve Stimulator (SNS)
5.5.7.1 SNS market, 2014-2026 (USD Million)
5.5.8 Vagus Nerve Stimulator (VNS)
5.5.8.1 VNS market, 2014-2026 (USD Million)
5.5.9 Others
5.5.9.1 Others market, 2014-2026 (USD Million)

Chapter 6 Electroceutical/Bioelectric Medicine Market: Segment Analysis, By Application, 2014-2026 (USD Million)
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2018 & 2026
6.3 Segment Dashboard
6.4 Global Electroceutical/Bioelectric Medicine Market, by Application, 2014 to 2026
6.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026
6.5.1 Arrhythmia
6.5.1.1 Arrhythmia Market, 2014-2026 (Usd Million)
6.5.2 Pain Managemnet
6.5.2.1 Pain Management Market, 2014-2026 (Usd Million)
6.5.3 Sensorineural Hearing Loss
6.5.3.1 Sensorineural Hearing Loss Market, 2014-2026 (Usd Million)
6.5.4 Parkinson’s Disease
6.5.4.1 Parkinson’s Disease Market, 2014-2026 (Usd Million)
6.5.5 Tremor
6.5.5.1 Tremor Market, 2014-2026 (Usd Million)
6.5.6 Depression
6.5.6.1 depression market, 2014-2026 (USD Million)
6.5.7 Treatment Resistant Depression (TRD)
6.5.7.1 TRD market, 2014-2026 (USD Million)
6.5.8 Epilepsy
6.5.8.1 ePILEPSY market, 2014-2026 (USD Million)
6.5.9 Urinary And Fecal Incontinence
6.5.9.1 Urinary and Fecal Incontinence market, 2014-2026 (USD Million)
6.5.10 Others
6.5.10.1 Others market, 2014-2026 (USD Million)

Chapter 7 Electroceutical/Bioelectric Medicine Market: Segment Analysis, By End Use, 2014-2026 (USD Million)
7.1 Definition and Scope
7.2 End Use Market Share Analysis, 2018 & 2026
7.3 Segment Dashboard
7.4 Global Electroceutical/Bioelectric Medicine Market, by End Use, 2014 to 2026
7.5 Market Size & Forecasts and Trend Analyses, 2014 to 2026
7.5.1 Hospitals
7.5.1.1 Hospitals Market, 2014-2026 (Usd Million)
7.5.2 Others
7.5.2.1 Others market, 2014-2026 (USD Million)

Chapter 8 Electroceutical/Bioelectric Medicine Market: Regional Market Analysis, By Type, Product, Application, End Use, 2014-2026 (USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2018 & 2026
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.5.1 North America
8.5.2 Europe
8.5.3 Asia Pacific
8.5.4 Latin America
8.5.5 Middle East and Africa
8.6 Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2026
8.7 North America
8.7.1 North America Market Estimates And Forecast, by Country, 2014-2026 (USD Million)
8.7.2 U.S.
8.7.2.1 U.S. Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.7.3 Canada
8.7.3.1 Canada Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.8 Europe
8.8.1 Europe Electroceutical/Bioelectric Medicine Market, by Country, 2014-2026 (USD Million)
8.8.2 UK
8.8.2.1 UK Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.8.3 Germany
8.8.3.1 Germany Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.8.4 France
8.8.4.1 France Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.8.5 Italy
8.8.5.1 Italy Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.8.6 Spain
8.8.6.1 Spain Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.9 Asia Pacific
8.9.1 Asia Pacific Electroceutical/Bioelectric Medicine Market, by Country, 2014-2026 (USD Million)
8.9.2 Japan
8.9.2.1 Japan Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.9.3 China
8.9.3.1 China Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.9.4 India
8.9.4.1 India Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.9.5 Singapore
8.9.5.1 Singapore Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.10 Latin America
8.10.1 Latin America Electroceutical/Bioelectric Medicine Market, by country, 2014-2026 (USD Million)
8.10.2 Brazil
8.10.2.1 Brazil Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.10.3 Mexico
8.10.3.1 Mexico Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.10.4 Argentina
8.10.4.1 Argentina Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.11 MEA
8.11.1 MEA Electroceutical/Bioelectric Medicine Market, by Country 2014-2026 (USD Million)
8.11.2 South Africa
8.11.2.1 South Africa Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)
8.11.3 Saudi Arabia
8.11.3.1 Saudi Arabia Electroceutical/Bioelectric Medicine Market, 2014-2026 (USD Million)

Chapter 9 Electroceutical/Bioelectric Medicine Market-Competitive Analysis
9.1 Market Participation Categorization
9.1.1 Market leader
9.1.2 Innovators
9.2 Public Companies
9.2.1 Company market position analysis
9.3 Private Companies
9.3.1 List of key emerging companies
9.4 Company Profiles
9.5 Medtronic
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Abbott
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Boston Scientific
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 Cochlear Ltd.
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Siemens Healthineers AG
9.9.1 Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic Initiatives
9.10 Biotronik
9.10.1 Company Overview
9.10.2 Product Benchmarking
9.10.3 Strategic Initiatives
9.11 Second Sight Medical Products, Inc.
9.11.1 Company Overview
9.11.2 Financial Performance
9.11.3 Product Benchmarking
9.11.4 Strategic Initiatives
9.12 LivaNova PLC
9.12.1 Company Overview
9.12.2 Financial Performance
9.12.3 Product Benchmarking
9.12.4 Strategic Initiatives
9.13 ElectroCore Inc.,
9.13.1 Company Overview
9.13.2 Product Benchmarking
9.13.3 Strategic Initiatives
9.14 Nevro Corp.
9.14.1 Company Overview
9.14.2 Financial Performance
9.14.3 Product Benchmarking
9.14.4 Strategic Initiatives
9.15 Sonova
9.15.1 Company Overview
9.15.2 Financial Performance
9.15.3 Product Benchmarking
9.15.4 Strategic Initiatives

Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Medtronic
  • Abbott
  • Boston Scientific
  • Cochlear Ltd.
  • Siemens Healthineers AG
  • Biotronik
  • Second Sight Medical Products, Inc.
  • LivaNova PLC
  • ElectroCore Inc.,
  • Nevro Corp.
  • Sonova
Note: Product cover images may vary from those shown
Adroll
adroll